Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-114304
Filing Date
2022-04-22
Accepted
2022-04-22 09:03:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d261564ddefa14a.htm DEFA14A 62922
2 GRAPHIC g261564amgen_letterhead-100.jpg GRAPHIC 10391
3 GRAPHIC g261564g06j74.jpg GRAPHIC 114077
4 GRAPHIC g261564g63w38.jpg GRAPHIC 7798
  Complete submission text file 0001193125-22-114304.txt   246590
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 22843578
SIC: 2836 Biological Products, (No Diagnostic Substances)